Nextage Therapeutics Ltd (TLV:NXTG)
Israel · Delayed Price · Currency is ILS · Price in ILA 38.80
-0.10 (-0.26%)
Sep 23, 2026, 3:38 PM IDT
Nextage Therapeutics Market Cap
Nextage Therapeutics has a market cap or net worth of 31.53 million as of September 23, 2026. Its market cap has increased by 10.09% in one year.
Market Cap
31.53M
Enterprise Value
38.66M
Revenue
2.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
38.80
ChartMarket Cap Chart
Since February 29, 2024, Nextage Therapeutics's market cap has increased from 12.50M to 31.53M, an increase of 152.25%. That is a compound annual growth rate of 43.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 31.53M | 32.71% |
| Dec 31, 2024 | 23.76M | 90.07% |
| Feb 29, 2024 | 12.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.55B |
| Amal Holdings A.D. | 2.19B |
| BrainsWay | 1.65B |
| Rafa Laboratories | 1.60B |
| Together Pharma | 37.09M |
| BioLineRx | 34.07M |
| Purple Biotech | 32.42M |
| Allmed Solutions | 31.89M |